Vic pharma manufacturer expands operations


Friday, 21 June, 2019

Vic pharma manufacturer expands operations

Melbourne-based company Australian Pharmaceutical Manufacturers (APM), a division of Pact Group, has opened expanded operations in the suburb of Keysborough, allowing the company to increase exports and create 44 new local jobs.

With support from the Victorian Government, the $6.9 million upgrade will allow APM, which offers contract manufacturing and packaging services for products including vitamin and mineral supplements, to take on more work from existing clients and increase its reach across Asia.

“The Victorian Government is busy walking the talk, actually investing in supporting manufacturing and breathing life into projects that grow employment and help Victorian business succeed,” said Pact Group Chairman Raphael Geminder.

“We all win when we get great collaboration between government and industry, and APM ... couldn’t have made this project come to life without the Victorian Government’s help.”

APM is the latest company to invest in Victoria’s medical technologies and pharmaceuticals sector, following recent significant investments by Praxis, CSL, Nutribiotech and Aspen Australia. This investment is a further boost to Victoria’s manufacturing industry, which contributes more than $30 billion to the economy and employs more than 270,000 people.

“Pharmaceuticals are Victoria’s highest-value manufactured export product, worth $1.5 billion to the state’s economy each year,” said Victorian Member for Keysborough and Minister for Jobs, Innovation and Trade Martin Pakula.

“We’re proud to support APM in their expansion efforts, helping them to capture growing international demand for Australian-manufactured products and create new local jobs.”

Image credit: ©iStockphoto.com/josemoraes

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Next-gen therapies could treat high-grade gliomas

Government funding will enable researchers to test a suite of next-generation therapies they have...

Bacteriophage cocktail to combat superbugs

Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...

Exclusive colostrum intake may reduce risk of food allergies

Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd